AeroLeads people directory · profile
Michael Friedman Email & Phone Number
Director, ML4 Foundation Board of Directors
at
Mucolipidosis Type IV (ML4) Foundation
1 work email found
@adverum.com
8 phones found area 916, 248, and 734
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Director, ML4 Foundation Board of Directors
Location
San Rafael, California, United States
Company size
Who is Michael Friedman? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Friedman is listed as Director, ML4 Foundation Board of Directors at Mucolipidosis Type IV (ML4) Foundation, a company with 3 employees, based in San Rafael, California, United States. AeroLeads shows a work email signal at adverum.com, phone signal with area code 916, 248, 734, and a matched LinkedIn profile for Michael Friedman.
Michael Friedman previously worked as Executive Director Global Medical Affairs Strategy at Apellis Pharmaceuticals and Executive Director, Clinical Development/Medical Affairs at Adverum Biotechnologies. Michael Friedman holds Ph.D., Cellular And Molecular Biology from University Of Michigan - Rackham Graduate School.
Company email context
Email format at Mucolipidosis Type IV (ML4) Foundation
This section adds company-level context without repeating Michael Friedman's masked contact details.
{first_initial}{last}@adverum.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Friedman. Compare company email patterns before reaching out.
Profile bio
About Michael Friedman
Passionate leader who empowers teams to achieve their full potential. Broad scientific and medical expertise in the pharmaceutical and biotechnology industries in gene therapy, neurodegenerative disease, inflammatory disease, and rare disease. Broad leadership experience from early development through post-marketing.
Listed skills include Stem Cells, Immunology, Molecular Biology, Biotechnology, and 32 others.
Current workplace
Michael Friedman's current company
Company context helps verify the profile and gives searchers a useful next step.
Mucolipidosis Type Iv (Ml4) Foundation
12 roles
Michael Friedman work experience
A career timeline built from the work history available for this profile.
Executive Director Global Medical Affairs Strategy
CurrentGlobal Medical Affairs Strategy and Evidence Generation—Geographic Atrophy
Mar 2024 - Present
Director, Ml4 Foundation Board Of Directors
CurrentProvide scientific guidance to the Board of Directors and the leadership of the Foundation, including guidance on grant requests from academic partners in the area of rare and ultrarare disease, lysosomal storage disorders, neuroinflammation, and gene therapyhttp://www.ml4.org/ML4 is a genetic disease causing mental retardation, retinal degeneration, and.
Jan 2015 - Present
Executive Director, Clinical Development/Medical Affairs
Clinical Development Study Lead for nAMD and DME Gene Therapy Trials/Extension StudiesWork closely with scientific and medical advisors and cross functional partners to better elucidate and mitigate the immune response to gene therapyDevelop the Scientific Communication PlatformEvidence Generation and Scientific Communication Strategy
Mar 2021 - Mar 2024
Senior Medical Director, Global Medical Affairs, Early Programs
Worked in the areas of rare disease gene therapy, neurodevelopmental and neurodegenerative diseaseGene Therapy for Rett Syndrome and Friedreich's AtaxiaDeveloped the Early Program Medical Affairs Strategy for Rett Syndrome and Friedreich's AtaxiaDeveloped intelligence plan for Early Program Medical Affairs for Rett Syndrome and Friedreich's AtaxiaServed as.
Jun 2020 - Mar 2021
Director Medical Affairs
Launched Zolgensma in Spinal Muscular AtrophyContributed to the development of the US Medical Plan and the Integrated Product Strategy for ZolgensmaDeveloped training and resources for the US field team in support of the Zolgensma launch as part of the US field leadership team
Feb 2019 - Jun 2020
Director Medical Affairs, Rheumatology
As a member of the Dermatology and Rheumatology Medical Leadership Team, I am responsible for the development and execution of the external tactics ad strategy in support of the overall medical strategyLed Rheumatology (Cosentyx) Field Medical Tactics Development in Psoriatic ArthritisLed Rheumatology (Cosentyx) Field Medical Tactics Development in.
Sep 2016 - Feb 2019
Regional Scientific Associate Director
Dermatology and RheumatologyLaunched ILARIS in SJIALaunched Xolair for CIU in DermatologyLaunched Cosentyx in PsoriasisLaunched Cosentyx in Psoriatic ArthritisLaunched Cosentyx in Ankylosing SpondylitisRe-established field medical affairs in CA for Novartis in Dermatology and RheumatologyNational coordinator for the Dermatology and Rheumatology external.
Feb 2013 - Sep 2016
Feb 2010 - Feb 2013
Principal Investigator, Manager Of Laboratory Operations
Thermogenesis Inc
- Regenerative Medicine Applications for Adult and Placental Mesenchymal Stem Cells
- Led a cross-functional research and development program defining the regenerative potential of placental, cord blood, bone marrow, and adipose MSC that led to the establishment of two veterinary stem cell clinics
- Led business development efforts for partnering with regenerative medicine and biomaterials companies
- Developed biomarker profiles for stem cells from multiple sources
- Developed cGMP manufacturing processes for processing, expanding and banking bone marrow, umbilical cord blood, umbilical cord matrix, and adipose MSC expansion
- Managed all biologics related verification and validation studies in support of product research and development
Feb 2008 - Jan 2010
Postdoctoral Researcher
- Gene Networks Regulating Osteoblast Differentiation
- Managed a research program on stem cells and regenerative medicine
- Used microarray analysis to evaluate BMP and Wnt induced signaling networks in human mesenchymal stem cells (hMSC) undergoing adipogenic and osteogenic differentiation
- Developed novel micro RNA-based retroviral vectors to knock-down osteoblast specific gene expression
- Developed in vivo models of bone formation
- Supervised and directed all laboratory patent applications
Jul 2006 - Feb 2008
Laboratory Manager
- Immunotherapy for Cancer
- Managed a project to redirect the immune response of T-cells to melanoma
- Studied T-cell trafficking to lymphatic tissue.
- Developed dendritic cell based vaccines for use in mouse tumor models.Gene Therapy for Cancer
- Managed a gene therapy project to develop next generation viral vectors for human applications
- Designed and constructed retroviral vectors encoding a melanoma antigen specific T-cell receptor.
Oct 1995 - Oct 2000
2 education records
Michael Friedman education
Ph.D., Cellular And Molecular Biology
University Of Michigan - Rackham Graduate School
Bs, Microbiology
University Of Michigan College Of Literature, Science, And The Arts
FAQ
Frequently asked questions about Michael Friedman
Quick answers generated from the profile data available on this page.
What company does Michael Friedman work for?
Michael Friedman works for Mucolipidosis Type IV (ML4) Foundation.
What is Michael Friedman's role at Mucolipidosis Type IV (ML4) Foundation?
Michael Friedman is listed as Director, ML4 Foundation Board of Directors at Mucolipidosis Type IV (ML4) Foundation.
What is Michael Friedman's email address?
AeroLeads has found 1 work email signal at @adverum.com for Michael Friedman at Mucolipidosis Type IV (ML4) Foundation.
What is Michael Friedman's phone number?
AeroLeads has found 8 phone signal(s) with area code 916, 248, 734 for Michael Friedman at Mucolipidosis Type IV (ML4) Foundation.
Where is Michael Friedman based?
Michael Friedman is based in San Rafael, California, United States while working with Mucolipidosis Type IV (ML4) Foundation.
What companies has Michael Friedman worked for?
Michael Friedman has worked for Mucolipidosis Type Iv (Ml4) Foundation, Apellis Pharmaceuticals, Adverum Biotechnologies, Novartis Gene Therapies, and Organogenesis.
Who are Michael Friedman's colleagues at Mucolipidosis Type IV (ML4) Foundation?
Michael Friedman's colleagues at Mucolipidosis Type IV (ML4) Foundation include Laura Willard.
How can I contact Michael Friedman?
You can use AeroLeads to view verified contact signals for Michael Friedman at Mucolipidosis Type IV (ML4) Foundation, including work email, phone, and LinkedIn data when available.
What schools did Michael Friedman attend?
Michael Friedman holds Ph.D., Cellular And Molecular Biology from University Of Michigan - Rackham Graduate School.
What skills is Michael Friedman known for?
Michael Friedman is listed with skills including Stem Cells, Immunology, Molecular Biology, Biotechnology, Regenerative Medicine, Lifesciences, Clinical Trials, and Life Sciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial